Meet Eric J. Margolis, MD

Medical School

Upstate Medical Center – Syracuse, NY

Internship & Residency

Mount Sinai Hospital – New York, NY

Languages Spoken

English

Ages Served

18+

Dr. Eric J. Margolis is a board-certified urologist in practice in northern New Jersey for more than twenty years. He specializes in all aspects of adult urology with an emphasis on urologic oncology, benign prostatic enlargement, stone disease and urinary incontinence.

After graduating Magna Cum Laude from Cornell University with a BA in chemistry, he received his MD from Upstate Medical Center in Syracuse, NY, and completed his residency in urology at Mount Sinai Hospital in New York City.

Dr. Margolis is currently the Chief of Urology at Englewood Hospital and Medical Center and Assistant Professor of Urology at the newly-accredited Seton Hall School of Medicine. He has been a Fellow of the American College of Surgeons for more than 18 years.

Dr. Margolis serves as Director of Clinical Research for New Jersey Urology where his research efforts center on urologic oncology. He is spearheading trials studying the precision of several diagnostic tests for prostate and bladder cancer. Additionally, he is the principal investigator for two clinical trials exploring new immunotherapy treatments for both early and late stage prostate cancer.

Dr. Margolis is proud to serve as one of the Spartan Investigators that published an original article in the New England Journal of Medicine in March of 2018 entitled “Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.”

As a physician, Dr. Margolis and his staff strive to care for his patients in a warm and nurturing environment.

SPECIALTIES

  • Clinical Research
  • Urologic Oncology
  • Enlarged Prostate (BPH)
  • Stone Disease
  • Urinary Incontinence

ENGLEWOOD

300 Grand Avenue
Englewood, NJ 07631

P. (201) 816-1900

Dr. Margolis has been involved in clinical research trials in urology for over ten years. He has been principal investigator on over 30 research trials and has worked closely with numerous pharmaceutical and device companies to explore new technologies in the urologic space. He is currently one of five researchers globally to be part of Medtronic pelvic research group studying sacral neurostimulation for voiding dysfunction.

Dr. Margolis is proud to be acknowledged by numerous top doctors lists, including New York Magazine, New Jersey Monthly, and Castle Connolly.

  • Fellow, American College of Surgeons
  • American Urological Association
  • Society for Urodynamics and Female Pelvic Health and Urogenital Reconstruction
  • Aetna
  • CHN
  • Cigna
  • Clover
  • Horizon Blue Cross Blue Shield of NJ
  • Emblem Health
  • Empire Blue Cross HMO (Contiguous County only)
  • Empire Blue Cross PPO
  • GHI
  • HealthNet Federal
  • Humana
  • Magnacare
  • Medicare
  • Multiplan
  • Oxford
  • Qualcare
  • Railroad Medicare
  • Tricare
  • UnitedHealthcare (excluding Medicare Plans)
  • US Family Health